injection of gene therapy for CMT

After a single injection, mice with a disease resembling type 1A Charcot-Marie-Tooth showed  improved strength and nerve signaling

posted on April 21, 2010 - 3:49pm
Mice with a disorder resembling type 1A Charcot-Marie-Tooth (CMT1A) disease that received a single intramuscular injection of genes for the protein neurotrophin 3 (NT3) showed improvements in grip strength, ability to stay on a rotating rod, and strength of nerve signals, investigators reported April 15, at the 2010 meeting of the American Academy of Neurology, held in Toronto.

New content is being added every day. Please check back again.